Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Applied DNA Sciences Inc APDN

Applied DNA Sciences, Inc. is a biotechnology company that develops, and markets deoxyribonucleic acid (DNA) based technology solutions. The Company is utilizing its LinearDNA large-scale polymerase chain reaction (PCR) based manufacturing platform. The Company’s proprietary platform produces large quantities of DNA for use in the nucleic acid-based in vitro diagnostics and preclinical nucleic... see more

Recent & Breaking News (NDAQ:APDN)

Applied DNA Subsidiary LineaRx Provides Cost and Quality Advantages to Technogenetics Diagnostic Solutions

Business Wire November 7, 2018

New Study: DNA Molecular Tagging is an Effective Tool to Authenticate Denim, One of the Toughest Fabrics

Business Wire November 5, 2018

GHCL, un acteur mondial du linge de maison, crée "CIRKULARITY", une plateforme de marques inspirée par le linge de lit "REKOOP" en polyester recyclé durable et traçable

Business Wire October 29, 2018

GHCL, a Global Home Textiles Player, Creates “CIRKULARITY”, a Brand Platform, Inspired By “REKOOP” Sustainable, Traceable, Recycled Polyester Bedding

Business Wire October 29, 2018

Applied DNA Enters FY2019 with Strong Business Momentum

Business Wire October 24, 2018

Applied DNA Subsidiary LineaRx Licenses CAR T Drug Candidate and Initiates Pre-Clinical Development of Non-Viral, Plasmid-Free CAR T Manufacturing Platform

Business Wire October 16, 2018

Applied DNA Appoints Industry Veteran Wayne Buchen Vice President of Strategic Sales for Textile Vertical

Business Wire October 4, 2018

LineaRx Secures New RNA Therapeutics Customers for Contract Research Services

Business Wire October 1, 2018

Applied DNA Expands Cannabis Tagging Portfolio to Address Large Growers

Business Wire September 25, 2018

Applied DNA Subsidiary, LineaRx, Inc. Signs Joint Development Agreement with Takis and Evvivax to Develop Linear-DNA Based Anti-Cancer Vaccines

Business Wire September 20, 2018

Applied DNA Forms Wholly Owned Subsidiary, LineaRx, to Develop Large-Scale, PCR-Produced DNA for Biotherapeutics

Business Wire September 18, 2018

Applied DNA Executes New Two-Year Contract with the U.S. Defense Logistics Agency

Business Wire September 11, 2018

Applied DNA Announces $1.65 Million Private Placement of Secured Convertible Notes

Business Wire September 4, 2018

Applied DNA Presenting Linear DNA for Gene Therapy at Boston Immuno-Oncology Summit

Business Wire August 27, 2018

Applied DNA Reports Fiscal Third Quarter 2018 Financial Results

Business Wire August 13, 2018

Applied DNA Schedules Fiscal 2018 Third Quarter Financial Results Conference Call for Monday, August 13, 2018 at 4:30 PM ET

Business Wire August 6, 2018

Applied DNA Sciences Reaches New Milestones in Therapeutic Contract Research and Contract Manufacturing of Linear DNA

Business Wire August 2, 2018

TheraCann Launches ETCH Biotrace™ Technology

PR Newswire August 1, 2018

Applied DNA Signs MOU with Everledger to Build CertainT® Blockchain Platform for High-end Product Markets

Business Wire July 31, 2018

Majority of American Consumers Concerned About Inauthentic Products; 73% Would Stop Purchases

Business Wire July 26, 2018